Current Cancer Drug Targets,volume 18,issue 3  (02-2018)

Period of time： 2018年3期

Publisher： Bentham Science Publishers

Founded in： 2001

Total resources： 135

E-ISSN： 1873-5576|18|3

ISSN： 1568-0096

Subject： R9 Pharmacy

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Current Cancer Drug Targets,volume 18,issue 3

Menu

Meet Our Editorial Board Member

Current Cancer Drug Targets,volume 18,issue 3 , Vol. 18, Iss. 3, 2018-02 , pp. 221-221

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Targeting STEAP1 Protein in Human Cancer: Current Trends and Future Challenges

Current Cancer Drug Targets,volume 18,issue 3 , Vol. 18, Iss. 3, 2018-02 , pp. 222-230

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Obesity and Cancer: Biological Links and Treatment Implications

Current Cancer Drug Targets,volume 18,issue 3 , Vol. 18, Iss. 3, 2018-02 , pp. 231-238

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Elaborating the Role of Natural Products on the Regulation of Autophagy and their Potentials in Breast Cancer Therapy

Current Cancer Drug Targets,volume 18,issue 3 , Vol. 18, Iss. 3, 2018-02 , pp. 239-255

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

The Complexity of DEK Signaling in Cancer Progression

Current Cancer Drug Targets,volume 18,issue 3 , Vol. 18, Iss. 3, 2018-02 , pp. 256-265

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

MicroRNA Key to Angiogenesis Regulation: MiRNA Biology and Therapy

Current Cancer Drug Targets,volume 18,issue 3 , Vol. 18, Iss. 3, 2018-02 , pp. 266-277

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Effects of PHA-665752 and Cetuximab Combination Treatment on In Vitro and Murine Xenograft Growth of Human Colorectal Cancer Cells with KRAS or BRAF Mutations

Current Cancer Drug Targets,volume 18,issue 3 , Vol. 18, Iss. 3, 2018-02 , pp. 278-286

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

HIF1A is Overexpressed in Medulloblastoma and its Inhibition Reduces Proliferation and Increases EPAS1 and ATG16L1 Methylation

Current Cancer Drug Targets,volume 18,issue 3 , Vol. 18, Iss. 3, 2018-02 , pp. 287-294

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Autophagy Inhibition in Childhood Nephroblastoma and the Therapeutic Significance

Current Cancer Drug Targets,volume 18,issue 3 , Vol. 18, Iss. 3, 2018-02 , pp. 295-303

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Total 9 item(s)